AP2015008515A0 - Medicinal lozenge based on ibuprofen sodium dihydrate - Google Patents

Medicinal lozenge based on ibuprofen sodium dihydrate

Info

Publication number
AP2015008515A0
AP2015008515A0 AP2015008515A AP2015008515A AP2015008515A0 AP 2015008515 A0 AP2015008515 A0 AP 2015008515A0 AP 2015008515 A AP2015008515 A AP 2015008515A AP 2015008515 A AP2015008515 A AP 2015008515A AP 2015008515 A0 AP2015008515 A0 AP 2015008515A0
Authority
AP
ARIPO
Prior art keywords
sodium dihydrate
ibuprofen sodium
medicinal
lozenge based
medicinal lozenge
Prior art date
Application number
AP2015008515A
Other languages
English (en)
Inventor
Nadine Harambillet
Jean-Francois Cordoliani
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48050846&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AP2015008515(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pf Medicament filed Critical Pf Medicament
Publication of AP2015008515A0 publication Critical patent/AP2015008515A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Otolaryngology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AP2015008515A 2012-11-14 2013-11-14 Medicinal lozenge based on ibuprofen sodium dihydrate AP2015008515A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1260815A FR2997856B1 (fr) 2012-11-14 2012-11-14 Pastille medicamenteuse a base d'ibuprofene sodique dihydrate
PCT/EP2013/073868 WO2014076203A1 (fr) 2012-11-14 2013-11-14 Pastille medicamenteuse a base d'ibuprofene sodique dihydrate

Publications (1)

Publication Number Publication Date
AP2015008515A0 true AP2015008515A0 (en) 2015-06-30

Family

ID=48050846

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2015008515A AP2015008515A0 (en) 2012-11-14 2013-11-14 Medicinal lozenge based on ibuprofen sodium dihydrate

Country Status (17)

Country Link
US (1) US20160287514A1 (fr)
EP (1) EP2919752A1 (fr)
JP (1) JP6258342B2 (fr)
KR (1) KR20150084919A (fr)
CN (1) CN104780907A (fr)
AP (1) AP2015008515A0 (fr)
AU (1) AU2013346775B2 (fr)
BR (1) BR112015010808A2 (fr)
CA (1) CA2890832A1 (fr)
CL (1) CL2015001308A1 (fr)
FR (1) FR2997856B1 (fr)
MA (1) MA38162B1 (fr)
MX (1) MX2015006011A (fr)
RU (1) RU2015122217A (fr)
TN (1) TN2015000176A1 (fr)
WO (1) WO2014076203A1 (fr)
ZA (1) ZA201504280B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7214331B2 (ja) * 2016-12-28 2023-01-30 小林製薬株式会社 医薬組成物
WO2019104050A1 (fr) * 2017-11-27 2019-05-31 Lodaat Pharmaceuticals Procédés de préparation de compositions curcuminoïdes
EP4017488A4 (fr) * 2019-08-22 2024-01-10 Applied Biological Laboratories, Inc. Compositions et procédés utilisant des médicaments anti-inflammatoires non stéroïdiens

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA34430C2 (uk) * 1991-05-13 2001-03-15 Дзе Бутс Компані Плс S(-)-2-(4-ізобутилфеніл)пропіонат натрію дигідрат, придатний для лікування запалення, болю і гіпертермії, фармацевтична композиція на його основі та спосіб одержання s(-)-2-(4-ізобутилфеніл)пропіонату натрію
GB9710521D0 (en) * 1997-05-22 1997-07-16 Boots Co Plc Process
CH693586A8 (de) * 2002-10-14 2003-12-15 Roche Consumer Health Ag Darreichungsform von Ibuprofen-Natrium.
FR2865648B1 (fr) 2004-02-03 2006-06-30 Philippe Perovitch Procede de diffusion de molecules insolubles en milieu aqueux et composition mettant en oeuvre ce procede
MXPA06014185A (es) * 2004-06-07 2007-04-16 Strides Arcolab Ltd Composicion farmaceutica que contiene una solucion estable y clara de medicamento anti-inflmatorio en capsulas de gelatina blanda, y proceso para producirlo.
JP2008509207A (ja) * 2004-08-12 2008-03-27 レキット ベンキーザー ヘルスケア （ユーケイ） リミテッド 溶融押出しにより作製するパラセタモール、ｎｓａｉｄ及び糖アルコールを含む顆粒
GB2423710A (en) * 2005-03-01 2006-09-06 Boots Healthcare Int Ltd Lozenge production process
BRPI0618273A2 (pt) * 2005-11-02 2011-08-23 Teikoku Pharma Usa, Inc. formulações de dosagem oral de ibuprofeno organolepticamente aceitáveis, métodos de produção e uso das mesmas
US20070276042A1 (en) * 2006-05-26 2007-11-29 Auspex Pharmaceuticals, Inc. Preparation and utility of substituted carboxylic acid compounds
CN102557918B (zh) * 2011-11-28 2013-08-21 海南永田药物研究院有限公司 一种布洛芬钠化合物及其制法

Also Published As

Publication number Publication date
CL2015001308A1 (es) 2015-08-28
US20160287514A1 (en) 2016-10-06
FR2997856B1 (fr) 2015-04-24
AU2013346775B2 (en) 2018-06-28
WO2014076203A1 (fr) 2014-05-22
MX2015006011A (es) 2015-09-10
ZA201504280B (en) 2017-09-27
EP2919752A1 (fr) 2015-09-23
CA2890832A1 (fr) 2014-05-22
RU2015122217A (ru) 2017-01-10
JP2015537019A (ja) 2015-12-24
KR20150084919A (ko) 2015-07-22
CN104780907A (zh) 2015-07-15
JP6258342B2 (ja) 2018-01-10
FR2997856A1 (fr) 2014-05-16
TN2015000176A1 (fr) 2016-10-03
MA38162A1 (fr) 2016-12-30
AU2013346775A1 (en) 2015-07-02
BR112015010808A2 (pt) 2017-07-11
MA38162B1 (fr) 2019-12-31

Similar Documents

Publication Publication Date Title
ZA201505815B (en) Tamper resistant pharmaceutical formulations
ZA201501977B (en) Orally administered medical composition
IL239566A0 (en) Abuse-resistant pharmaceutical formulations
ZA201407373B (en) Novel pharmaceutical formulations
IL232305B (en) Pharmacy preparations
ZA201409020B (en) Pharmaceutical formulation
ZA201405797B (en) Pharmaceutical dosage form
ZA201507576B (en) Pharmaceutical combination drug
AP2015008208A0 (en) Pharmaceutical administration forms comprising
SG11201509194SA (en) Radiomitigating pharmaceutical formulations
ZA201600027B (en) Pharmaceutical preparation
ZA201504280B (en) Medicinal lozenge based on ibuprofen sodium dihydrate
AP3309A (en) Ibuprofen chewable tablet
ZA201405354B (en) Antacid tablet
BR112014021433A2 (pt) formulações farmacêuticas
GB201211406D0 (en) Pharmaceutical formulations
GB201211403D0 (en) Pharmaceutical formulations
ZA201502354B (en) Pharmaceutical dosage form
ZA201506465B (en) Pharmaceutical preparation
GB201107476D0 (en) Novel pharmaceutical lozenge
PT2833866T (pt) Produtos farmacêuticos mastigáveis moles
TH148781B (th) สารละลายสำหรับการให้ทางช่องปาก